From: An effective stability indicating RP-HPLC method for simultaneous estimation of Dolutegravir and Lamivudine in bulk and their tablet dosage form
Dolutegravir
Lamivudine
Concentration (μg/mL)
Peak area
5
2,011,389
30
5,499,384
7.5
3,113,353
45
8,303,431
10
4,166,851
60
10,887,444
12.5
5,300,175
75
13,300,994
15
6,209,262
90
15,591,086
R2
0.9989
0.9984